for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

SenesTech Inc

SNES.OQ

Latest Trade

1.75USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1.32

 - 

16.60

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
1.75
Open
--
Volume
--
3M AVG Volume
3.94
Today's High
--
Today's Low
--
52 Week High
16.60
52 Week Low
1.32
Shares Out (MIL)
3.40
Market Cap (MIL)
5.64
Forward P/E
--
Dividend (Yield %)
--

Next Event

Senestech Inc Annual Shareholders Meeting

Latest Developments

More

Senestech Reports QTRLY Loss Per Share Of $0.59

Senestech Reports Qtrly Loss Per Share $1.69

Senestech Files For Offering Of Up To 189,600 Common Stock By Security Holders

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About SenesTech Inc

SenesTech, Inc. is a biotechnology company that has developed a technology for managing animal pest populations, initially rat populations, through fertility control. Its product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. Its pipeline includes feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Its Feral animal fertility control has its application in the population management segment and targets feral dogs and hogs. Its Non-Surgical Spay and Neutering have its application in companion animal health, and targets companion dogs and cats. The Company's Boar taint has its application in food production and safety and targets boars.

Industry

Chemical Manufacturing

Contact Info

3140 N Caden Ct Ste 1

FLAGSTAFF, AZ

86004-9428

United States

+1.928.7794143

https://senestech.com/

Executive Leadership

Jamie Bechtel Morrison

Independent Chairman of the Board

Kenneth Siegel

Chief Executive Officer, Director

Thomas C. Chesterman

Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary

Steve Krause

Executive Vice President of Sales and Marketing

Kim Patrice Wolin

Executive Vice President - Operations, Secretary

Key Stats

Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019

0.0K

2020(E)

0.0K
EPS (USD)

2017

-22.400

2018

-12.600

2019

-7.690

2020(E)

-2.930
Price To Earnings (TTM)
--
Price To Sales (TTM)
27.13
Price To Book (MRQ)
1.15
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
16.92
LT Debt To Equity (MRQ)
14.59
Return on Investment (TTM)
-179.39
Return on Equity (TTM)
-146.48

Latest News

Latest News

BRIEF-Senestech Reports Qtrly Loss Per Share $1.69

* SENESTECH ANNOUNCES FIRST QUARTER 2020 FINANCIAL AND OPERATIONAL RESULTS

BRIEF-Senestech - Notified Nasdaq That CEO Became Aware Of Inadvertent Noncompliance By Co

* SENESTECH - NOTIFIED NASDAQ THAT CEO BECAME AWARE OF INADVERTENT NONCOMPLIANCE BY CO

BRIEF-Senestech Files For Offering Of Up To 189,600 Common Stock By Security Holders

* SENESTECH INC FILES PROSPECTUS RELATES TO PROPOSED RESALE OR OTHER DISPOSITION OF UP TO 189,600 OF COMMON STOCK BY SELLING SECURITYHOLDERS Source text for Eikon: Further company coverage:

BRIEF-SenesTech Launches "Direct To Consumer" Program For ContraPest

* SENESTECH LAUNCHES "DIRECT TO CONSUMER" PROGRAM FOR CONTRAPEST® Source text for Eikon: Further company coverage:

BRIEF-Senestech Inc Announces $0.5 Mln Registered Direct Offering Priced At-Market

* SENESTECH INC - ANNOUNCES $0.5 MILLION REGISTERED DIRECT OFFERING PRICED AT--MARKET

BRIEF-Senestech Says Have Regained Compliance With Nasdaq Listing Rule

* SENESTECH INC - HAVE REGAINED COMPLIANCE WITH NASDAQ LISTING RULE Source text: (https://bit.ly/2PevDqa) Further company coverage:

BRIEF-SenestechQ1 Loss Per Share $0.16

* SENESTECH ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS

BRIEF-Senestech Inc Enters Termination Agreement With Neoventa Solutions​

* SENESTECH INC - ON FEB 7, ENTERED TERMINATION AGREEMENT WITH RESPECT TO AGREEMENT DATED SEPT 26, 2015 BETWEEN CO AND NEOVENTA SOLUTIONS

BRIEF-CVI Investments reports 7.9 percent passive stake in Senestech as of Nov 17

* CVI INVESTMENTS INC REPORTS A 7.9 PERCENT PASSIVE STAKE IN SENESTECH INC AS OF NOVEMBER 17, 2017 - SEC FILING Source text : [ID:http://bit.ly/2AEd4WC] Further company coverage:

BRIEF-Sabby Volatility Warrant Master Fund reports 7.92 pct passive stake in Senestech

* Sabby Volatility Warrant Master Fund reports 7.92 percent passive stake in Senestech as of November 17 - SEC filing Source text: (http://bit.ly/2jcuD51) Further company coverage:

BRIEF-SenesTech announces pricing of public offering of common stock and warrants to purchase common stock

* SenesTech announces pricing of public offering of common stock and warrants to purchase common stock

BRIEF-Senestech Inc files for offering up to 2.5 million shares of co's common stock

* Senestech Inc files for offering up to 2.5 million shares of co's common stock and warrants to purchase 625,000 shares of common stock Source text: (http://bit.ly/2m7wb52) Further company coverage:

BRIEF-SenesTech announces third quarter financial and operational results

* SenesTech announces third quarter financial and operational results

BRIEF-SenesTech signs a distribution agreement with Univar for ContraPest

* SenesTech signs a distribution agreement with Univar for ContraPest

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up